1-19 of 19
Zhongjun Xia, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety, Tolerability and Efficacy of Orelabrutinib, Once a Day, to Treat Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia

Free
Wei Xu, MD PhD, Yongping Song, Zengjun Li, Shenmiao Yang, Lihong Liu, Yu Hu, Wei Zhang, Jianfeng Zhou, Sujun Gao, PhD, Kaiyang Ding, Huilai Zhang, MD, Zunmin Zhu, MD, Shunqing Wang, Bing Xu, Jianda Hu, PhD, Ting Liu, MD, Chunyan Ji, Zhongjun Xia, MD, Yan Li, PhDMD, Xin Wang, MD PhD, Zhixin Xu, Renbin Zhao, Bin Zhang, PhD, Alan Zhu, Jianyong Li, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4319.
https://doi.org/10.1182/blood-2019-123331
Published: 2019
Journal Articles

Old Drugs with New Tricks: Rituximab in Combination with Albumin-Bound paclitaxel and Pegylated Liposomal Doxorubicin in the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma

Free
Liang Wang, Hua Wang, PhD, Xiao-qin Chen, Wei-da Wang, Zhongjun Xia, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2827.
https://doi.org/10.1182/blood.V130.Suppl_1.2827.2827
Published: 2017
Journal Articles

PD-L1 Is up-Regulated By EBV-Driven LMP1 through NF-κb Pathway and Correlates with Poor Prognosis in Natural Killer/T-Cell Lymphoma

Free
Xi-Wen Bi, Hua Wang, Wen-Wen Zhang, Zhongjun Xia, MD, Yu-jing Zhang, Liang Wang, MD
Journal: Blood
Blood (2016) 128 (22): 4134.
https://doi.org/10.1182/blood.V128.22.4134.4134
Published: 2016
Journal Articles

A Prospective Study of Thyomosin α1 and Intravenous Immunoglobulin Role to Prevent the Infectious Pneumonia Related to Rituximab Based Immuno-Chemotherapy for B Cell Lymphoma

Free
Tongyu Lin, Raj Shrestha Prem, He Huang, Xueying Li, Huangming Hong, Mengping Zhang, Xiaojie Fang, Zhao Wang, Chengcheng Guo, Zhongjun Xia, MD
Journal: Blood
Blood (2016) 128 (22): 5394.
https://doi.org/10.1182/blood.V128.22.5394.5394
Published: 2016
Journal Articles

Phase 2 Trial of Concurrent Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-Induced Peripheral Neuropathy in Patients of Multiple Myeloma

Free
Liang Wang, MD, Zhongjun Xia, MD, Xiaoqin Chen, MD
Journal: Blood
Blood (2015) 126 (23): 5399.
https://doi.org/10.1182/blood.V126.23.5399.5399
Published: 2015
Journal Articles

High Level of Soluble Interleukin-2 Receptor in Serum Predicts Treatment Resistance and Poor Progression Free Survival in Multiple Myeloma

Free
Liang Wang, MD, Zhongjun Xia, MD
Journal: Blood
Blood (2015) 126 (23): 5332.
https://doi.org/10.1182/blood.V126.23.5332.5332
Published: 2015
Journal Articles

RCHOP-21 Vs. RCHOP-14 for the Treatment of Newly Diagnosed Diffuse Large B Cell Lymphoma: A Prospective Randomized Phase III Clinical Trial from Cswog

Free
Tongyu Lin, He Huang, Xueying Li, Chengcheng Guo, Huangming Hong, Xiaohong Fu, Xiaoting Lin, Xiaojie Fang, Zhao Wang, Zhongjun Xia, MD
Journal: Blood
Blood (2015) 126 (23): 2690.
https://doi.org/10.1182/blood.V126.23.2690.2690
Published: 2015
Journal Articles

Clinical Outcome of P-Gemox ( Pegaspargase, Gemcitabine, Oxaliplatin ) for the Patients with Newly Diagnosed Stage III/IV or Relapsed/Refractory Extranodal Natural Killer/T Cell Lymphoma

Free
Huiqiang Huang, MD, Yan Gao, XiaoXiao Wang, Qingqing Cai, MD, QiChun Cai, Bing Bai, Wei Zhao, Zheng Yan, Wenqi Jiang, MD PhD, Zhongjun Xia, MD, ZhiMing Li
Journal: Blood
Blood (2015) 126 (23): 1521.
https://doi.org/10.1182/blood.V126.23.1521.1521
Published: 2015
Journal Articles

Predictive Value of Interim 18 f-FDG PET-CT Scans on Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Study

Free
He Huang, Jiatian Lin, Chengcheng Guo, Shanshan Li, MD, Huangming Hong, Xueying Li, Mengping Zhang, Zhongjun Xia, MD, Tongyu Lin
Journal: Blood
Blood (2015) 126 (23): 1458.
https://doi.org/10.1182/blood.V126.23.1458.1458
Published: 2015
Journal Articles

A Prospective, Self-Controlled and Randomized Study about the Optimal Timing of Leucovorin Rescue after High Dose Methotrexate Management

Free
Tongyu Lin, Xueying Li, Tingzhi Liu, He Huang, Huangming Hong, Chengcheng Guo, Xiaohong Fu, Xiaojie Fang, Zhao Wang, Zhongjun Xia, MD, Xiaoting Lin
Journal: Blood
Blood (2015) 126 (23): 3956.
https://doi.org/10.1182/blood.V126.23.3956.3956
Published: 2015
Journal Articles

Longterm Outcome of Induction Chemotherapy of P-Gemox Regimen Followed By Extensive Involved-Field Radiotherapy(EIFRT) for Newly Diagnosed Stage I/II Extranodal Natural Killer/T-Cell Lymphoma---a Single Center Experience

Free
Huiqiang Huang, MD, Yan Gao, XiaoXiao Wang, Qingqing Cai, MD, QiChun Cai, Bing Bai, Zheng Yan, Wenqi Jiang, Zhongjun Xia, MD, ZhiMing Li
Journal: Blood
Blood (2015) 126 (23): 3936.
https://doi.org/10.1182/blood.V126.23.3936.3936
Published: 2015
Journal Articles

Consolidative Treatment after Salvage Chemotherapy Improved Prognosis in Patients with Relapsed Extranodal Natural Killer/T-Cell Lymphoma

Free
Xi-Wen Bi, Wen-Wen Zhang, Jia-Jia Huang, Zhongjun Xia, MD, Zhi-Ming Li, Wenqi Jiang, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5086.
https://doi.org/10.1182/blood.V126.23.5086.5086
Published: 2015
Journal Articles

The Role of Interim F-18 FDG PET/CT in Patients of T Lymphoblastic Leukemia/Lymphoma Treated with ALL-Type Regimens

Free
Liang Wang, MD, Zhongjun Xia, MD, Xiaoqin Chen, MD, Wen Long, MD
Journal: Blood
Blood (2015) 126 (23): 5015.
https://doi.org/10.1182/blood.V126.23.5015.5015
Published: 2015
Journal Articles

Predictive value of therapeutic monitoring with plasma Epstein-Barr virus DNA in Extranodal NK/T cell lymphoma, nasal type

Free
Chengcheng Guo, He Huang, MD, Ying Tian, Xueying Li, Mengping Zhang, Huangming Hong, MD, Xiaohong Fu, Xiaoting Lin, Shanshan Li, Raj Shrestha Prem, Zhongjun Xia, MD, Tongyu Lin, MDPhD
Journal: Blood
Blood (2014) 124 (21): 5363.
https://doi.org/10.1182/blood.V124.21.5363.5363
Published: 2014
Journal Articles

Predictive Value of Interim 18 f-FDG PET-CT Scans on Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Study of Chinese Southwest Oncology Group (CSWOG)

Free
He Huang, MD, Jia Tian Lin, Chengcheng Guo, Huangming Hong, MD, Raj Shrestha Prem, Xueying Li, Mengping Zhang, Shanshan Li, Xiaojie Fang, Zhao Wang, Zhongjun Xia, MD, Tongyu Lin, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3011.
https://doi.org/10.1182/blood.V124.21.3011.3011
Published: 2014
Journal Articles

A Novel and Significant Predictor in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: The Prognostic Nutritional Index (PNI)

Free
Qingqing Cai, MD PhD, Kailin Chen, MD, Huilan Rao, MDPhD, Wenqi Jiang, MD PhD, Huiqiang Huang, MD, Tongyu Lin, MDPhD, Zhongjun Xia, MD
Journal: Blood
Blood (2014) 124 (21): 1650.
https://doi.org/10.1182/blood.V124.21.1650.1650
Published: 2014
Journal Articles

A New Prognostic Model for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type

Free
Qingqing Cai, MD, PhD, Xiaolin Luo, MD, Ken H. Young, MD, Huiqiang Huang, MD, PhD, Guanrong Zhang, MD, Tongyu Lin, MD, PhD, Wenqi Jiang, MD, PhD, Zhongjun Xia, MD
Journal: Blood
Blood (2013) 122 (21): 1769.
https://doi.org/10.1182/blood.V122.21.1769.1769
Published: 2013
Journal Articles

Efficacy and Safety Of Pegaspargase With Gemcitabine and Oxaliplatin In Patients With Treatment-naïve, Refractory Extranodal Natural Killer/T-Cell Lymphoma: A Single-Centre Experience

Free
Yan Gao, M.D., Hui-qiang Huang, MD, PhD, Cai QiChun, XiaoXiao Wang, M.D., Ph.D., QinfQing Cai, Zhongjun Xia, MD, Bing Bai, Wei Zhao, Wenqi Jiang, MD, PhD, ZhongZhen Guan
Journal: Blood
Blood (2013) 122 (21): 642.
https://doi.org/10.1182/blood.V122.21.642.642
Published: 2013
Journal Articles

Long-Term Outcomes of Patients with Newly Diagnosed NK/T-Cell Lymphoma Treated by EPOCH Regimen.

Free
Huiqiang Huang, Zexiao Lin, Xubing Lin, Qingqing Cai, Zhongjun Xia, MD, Wenqi Jiang
Journal: Blood
Blood (2009) 114 (22): 2689.
https://doi.org/10.1182/blood.V114.22.2689.2689
Published: 2009